First test of new injection in healthy women begins
NCT ID NCT07118085
Summary
This is an early-stage study to check the safety and basic effects of a new injection called IMC-003. It will involve 56 healthy women who have gone through menopause. The main goal is to see how the body handles the drug and to identify any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chengdu Xinhua hospital
RECRUITINGChengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.